This is a stock you shouldn't hesitate to buy on the dip. Novo Nordisk (NVO 0.71%) has been a great investment over the past few years. Since the start of 2022, shares of the Danish healthcare giant have risen by 120%, far outstripping the S&P 500's return of just 8%. The company is a big name in diabetes care and weight loss, with many drugs that can help people in those areas. And despite its already strong returns of late, there is still much more upside for the stock. That's because the healthcare compa ...